We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · November 24, 2020

AHA 2020: Sotagliflozin Demonstrates Benefits in Diabetic Patients With Acute Decompensated Heart Failure or Chronic Kidney Diseases

SOLOIST-WHF and SCORED trials demonstrate reductions in cardiovascular death or hospitalizations/urgent visits for heart failure

PracticeUpdate Editorial Team

 

Further Reading